List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 704 studies with search of:   "Etoposide"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
Conditions: Gliosarcoma;   Glioblastoma
Intervention: Drug: Vandetanib and Etoposide
2 Active, not recruiting Ph II Bev + Either Temozolomide/Etoposide for GBM Pts Who Have Failed Bev + Irinotecan
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Temodar, Etoposide & Irinotecan
3 Recruiting Ph II Bevacizumab + Etoposide for Pts w Recurrent MG
Conditions: Glioblastoma;   Gliosarcoma
Intervention: Drug: Bevacizumab and Etoposide
4 Recruiting GCS-100 in Combination With Etoposide and Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Condition: Diffuse Large B-Cell Lymphoma, Relapsed or Refractory
Interventions: Drug: GCS-100;   Drug: Etoposide; Dexamethasone
5 Recruiting Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer
Condition: Small Cell Lung Carcinoma, Extensive Disease
Interventions: Drug: Cisplatin + etoposide;   Drug: Epirubicin + ifosfamide + etoposide
6 Not yet recruiting Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer
Condition: HER-2 Positive Metastatic Breast Cancer
Interventions: Drug: Etoposide;   Drug: Trastuzumab
7 Recruiting Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children
Conditions: Recurrent Brain Tumors;   Supratentorial PNETs;   Medulloblastomas;   Ependymomas
Interventions: Drug: carboplatin;   Drug: etoposide;   Drug: temozolomide;   Drug: thiotepa, carboplatin, etoposide;   Drug: temozolomide, thiotepa;   Procedure: autologous stem cell transplantation;   Drug: etoposide;   Drug: trofosfamid/etoposide
8 Recruiting Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Interventions: Drug: Cisplatin;   Drug: Etoposide;   Drug: Placebo;   Drug: Cisplatin;   Drug: Etoposide;   Drug: ZD6474
9 Recruiting Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Interventions: Drug: Vorinostat, Carboplatin, Etoposide;   Other: Vorinostat, Carboplatin, Etoposide
10 Recruiting Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate With or Without Sodium Thiosulfate in Treating Patients With High-Grade Glioma
Conditions: Brain and Central Nervous System Tumors;   Cancer-Related Problem/Condition
Interventions: Drug: carboplatin;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: etoposide phosphate;   Drug: sodium thiosulfate
11 Recruiting AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia
Condition: Leukemia, Myeloid, Acute
Interventions: Drug: AMD3100;   Drug: Mitoxantrone;   Drug: Etoposide;   Drug: Cytarabine
12 Recruiting Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Etoposide;   Drug: Interferon Alpha
13 Recruiting A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Interventions: Drug: cisplatinum or carboplatin and e.g.etoposide.;   Drug: cisplatinum or carboplatin and e.g.etoposide+enoxaparin
14 Completed A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer
Condition: Neoplasms
Interventions: Drug: Thalidomide;   Drug: Celecoxib;   Drug: Etoposide;   Drug: Cyclophosphamide
15 Recruiting STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study
Condition: Small Cell Lung Cancer
Interventions: Drug: cisplatin;   Drug: etoposide;   Drug: cisplatin;   Drug: etoposide
16 Active, not recruiting Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: Gemcitabine, Etoposide
17 Suspended Rituximab, Carboplatin, Cyclophosphamide, and Etoposide or Etoposide Phosphate Given With Osmotic Blood-Brain Barrier Disruption Plus Sodium Thiosulfate and Cytarabine in Treating Patients With Refractory or Recurrent Primary CNS Lymphoma
Conditions: Cancer-Related Problem/Condition;   Lymphoma
Interventions: Drug: carboplatin;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: etoposide;   Drug: etoposide phosphate;   Drug: filgrastim;   Drug: pegfilgrastim;   Drug: rituximab;   Drug: sodium thiosulfate;   Procedure: blood-brain barrier disruption chemotherapy
18 Active, not recruiting Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma
Conditions: Hodgkin Lymphoma;   Lymphoma
Interventions: Drug: Bortezomib;   Drug: Carboplatin;   Drug: Etoposide;   Drug: Ifosfamide;   Drug: Mesna
19 Completed Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st-Line Extensive Disease Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Interventions: Drug: Intravenous topotecan/cisplatin;   Drug: Intravenous etoposide/cisplatin
20 Recruiting Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)
Conditions: Hodgkin's Disease;   Lymphoma
Intervention: Drug: rituximab, cyclophosphamide, etoposide, prednisone, vorinostat and QOL questionnaire, peg-filgrastim or filgrastim

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services